SI1596841T1 - Terapevtski sistem amoksicilina in klavulanske kisline - Google Patents

Terapevtski sistem amoksicilina in klavulanske kisline

Info

Publication number
SI1596841T1
SI1596841T1 SI200430999T SI200430999T SI1596841T1 SI 1596841 T1 SI1596841 T1 SI 1596841T1 SI 200430999 T SI200430999 T SI 200430999T SI 200430999 T SI200430999 T SI 200430999T SI 1596841 T1 SI1596841 T1 SI 1596841T1
Authority
SI
Slovenia
Prior art keywords
amoxicillin
clavulanic acid
therapeutic system
dosage
pharmaceutical composition
Prior art date
Application number
SI200430999T
Other languages
English (en)
Inventor
Janez Kerc
Jerneja Opara
Osel Maja Jenko
Original Assignee
Lek Pharmaceuticals D.D.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SI200300044A external-priority patent/SI21401A/sl
Priority claimed from SI200300245A external-priority patent/SI21601A/sl
Application filed by Lek Pharmaceuticals D.D. filed Critical Lek Pharmaceuticals D.D.
Publication of SI1596841T1 publication Critical patent/SI1596841T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891Coated capsules; Multilayered drug free capsule shells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
SI200430999T 2003-02-21 2004-02-20 Terapevtski sistem amoksicilina in klavulanske kisline SI1596841T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SI200300044A SI21401A (sl) 2003-02-21 2003-02-21 Terapevtski sistem
SI200300245A SI21601A (sl) 2003-09-24 2003-09-24 Terapevtski sistem
PCT/SI2004/000010 WO2004073695A1 (en) 2003-02-21 2004-02-20 Therapeutic system comprising amoxicillin and clavulanic acid
EP04713281A EP1596841B1 (en) 2003-02-21 2004-02-20 Therapeutic system comprising amoxicillin and clavulanic acid

Publications (1)

Publication Number Publication Date
SI1596841T1 true SI1596841T1 (sl) 2009-06-30

Family

ID=32911559

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200430999T SI1596841T1 (sl) 2003-02-21 2004-02-20 Terapevtski sistem amoksicilina in klavulanske kisline

Country Status (11)

Country Link
US (1) US20060121106A1 (sl)
EP (1) EP1596841B1 (sl)
AT (1) ATE410152T1 (sl)
BR (1) BRPI0407438A (sl)
CA (1) CA2516327C (sl)
DE (1) DE602004016963D1 (sl)
EA (1) EA011215B1 (sl)
MX (1) MXPA05008843A (sl)
PL (1) PL213804B1 (sl)
SI (1) SI1596841T1 (sl)
WO (1) WO2004073695A1 (sl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7527807B2 (en) 2000-06-21 2009-05-05 Cubist Pharmaceuticals, Inc. Compositions and methods for increasing the oral absorption of antimicrobials
EP1681050A1 (en) * 2005-01-13 2006-07-19 Strides Arcolab Limited Dispersible sustained release pharmaceutical compositions
NZ563271A (en) * 2005-04-29 2009-12-24 Cubist Pharm Inc Therapeutic compositions
WO2007067770A2 (en) * 2005-12-08 2007-06-14 Advancis Pharmaceutical Corporation Pharmaceutical compositions and methods for improved bacterial eradication
US8357394B2 (en) * 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
WO2008029417A2 (en) * 2006-09-04 2008-03-13 Matrix Laboratories Limited Pharmaceutical formulation for use in hiv therapy
CA2788659C (en) * 2010-02-24 2015-05-05 Pfizer Inc. Veterinary compositions
MX2014008375A (es) * 2012-01-10 2017-07-27 Spector Michael Formulaciones pedriaticas de supspension oral de amoxicilina y clauvulanato de potasio y metodo para su uso.
CA2864088C (en) * 2012-02-08 2020-04-28 Supernus Pharmaceuticals, Inc. Modified release formulations of viloxazine
US20140279169A1 (en) * 2013-03-15 2014-09-18 Toyota Motor Sales, U.S.A., Inc. Method for generating vehicle repair estimate reports based on predictive estimating
CA2944900C (en) 2014-04-04 2023-02-28 Pharmaquest International Center, LLC Disintegrating monolithic modified release tablets containing quadri-layer extended release granules

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5512411B2 (sl) * 1974-03-12 1980-04-02
US4083956A (en) * 1976-04-29 1978-04-11 The Procter & Gamble Company Anhydrous antiperspirant creams
US5443459A (en) * 1991-01-30 1995-08-22 Alza Corporation Osmotic device for delayed delivery of agent
GB9407386D0 (en) * 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
JP2959423B2 (ja) * 1994-12-01 1999-10-06 シオノギクオリカプス株式会社 カプセル用皮膜組成物
EP1330236A2 (en) * 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin

Also Published As

Publication number Publication date
CA2516327C (en) 2012-04-17
EA200501223A1 (ru) 2006-04-28
MXPA05008843A (es) 2005-10-18
ATE410152T1 (de) 2008-10-15
PL377683A1 (pl) 2006-02-06
US20060121106A1 (en) 2006-06-08
CA2516327A1 (en) 2004-09-02
EA011215B1 (ru) 2009-02-27
EP1596841A1 (en) 2005-11-23
EP1596841B1 (en) 2008-10-08
WO2004073695A1 (en) 2004-09-02
DE602004016963D1 (en) 2008-11-20
PL213804B1 (pl) 2013-05-31
BRPI0407438A (pt) 2006-02-07

Similar Documents

Publication Publication Date Title
HK1076605A1 (en) Formulations
TWI265812B (en) Pharmaceutical safety dosage forms
TW200633730A (en) Oral disintegrating dosage forms
IL149147A0 (en) Use of oxcarbazepine for the manufacture of oral dosage form medicament
WO2008069941A3 (en) Modified release ibuprofen solid oral dosage form
EA200700049A1 (ru) Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением
SG158863A1 (en) Intravenous formulations of pde-5 inhibitors
HK1087336A1 (en) Pharmaceutical composition comprising lumiracoxib
WO2006108692A3 (en) Dosage form for oral administration of a vitamin
TN2010000135A1 (en) Galenical formulations of organic compounds
HRP20041092A2 (en) New pharmaceutical compositions containing filbanserin polymorph a
ATE298324T1 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
SI1596841T1 (sl) Terapevtski sistem amoksicilina in klavulanske kisline
BR0314129A (pt) Formulações de liberação modificadas de oxcarbazepina e derivados destas
MXPA06000332A (es) Nueva composicion farmaceutica solida que comprende amisulprida.
DE60124144D1 (de) Pharmazeutische zusammenstellungen zur verstärkung der artzneimitteleffekte
BR0311642A (pt) Formulação de divalproex de sódio de liberação aumentada
TW200503785A (en) Dosage form containing (S)-pantoprazole as active ingredient
WO2004024128A3 (en) Modified release ketoprofen dosage form
WO2004033484A3 (en) Use of stable glutamine derivatives to improve drug absorption
EA200400691A1 (ru) Получение чистых стереоизомеров трицикло[5,2,1,02,6]дец-9-ил-ксантогената и содержащие их лекарственные средства
AU2003202550A1 (en) Pharmaceutical formulations with modified release
BR0311209A (pt) Método de produção de unidades de dosagem farmacêuticas para administração oral, uso de etonogestrel, e, tablete
EA200500957A1 (ru) Применение l-допа, его производных и лекарственных средств, содержащих эти соединения, для профилактики психотических заболеваний
MD20040296A (ro) Compoziţie farmaceutică, conţinând oxcarbazepină cu eliberare prelungită a ingredientului activ